Chemical probes for drug-resistance assessment by binding competition (RABC): oseltamivir susceptibility evaluation.

@article{Cheng2013ChemicalPF,
  title={Chemical probes for drug-resistance assessment by binding competition (RABC): oseltamivir susceptibility evaluation.},
  author={Ting-Jen Rachel Cheng and Shi-Yun Wang and W. Wen and Ching-Yao Su and Mengi Lin and W. Huang and Ming-Tsan Liu and H L Wu and Nung-Sen Wang and Chung-Kai Cheng and Chun-Lin Chen and Chien-Tai Ren and Chung-Yi Wu and Jim-Min Fang and Y E Cheng and C. -H. Wong},
  journal={Angewandte Chemie},
  year={2013},
  volume={52 1},
  pages={366-70}
}
The wizard of OS (resistance): the binding difference of neuraminidase inhibitors (zanamivir versus oseltamivir (OS)) was used to establish an assay to identify the influenza subtypes that are resistant to OS but still sensitive to zanamivir. This assay used a zanamivir-biotin conjugate to determine the OS susceptibility of a wide range of influenza viruses and over 200 clinical isolates.